Here we report that DOCK2 activation in CLL in response to anti–μ or Wnt5a also is associated with its tyrosine phosphorylation, as noted in recent studies on T lymphocytes stimulated with chemokine [35]. Here, DOCK2 is linked to B-cell chronic lymphocytic leukemia.